0001415889-23-004083.txt : 20230303 0001415889-23-004083.hdr.sgml : 20230303 20230303161229 ACCESSION NUMBER: 0001415889-23-004083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Napolitano Richard J CENTRAL INDEX KEY: 0001599417 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 23704063 MAIL ADDRESS: STREET 1: MSCI INC., 7 WORLD TRADE CENTER STREET 2: 250 GREENWICH STREET, 49TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 form4-03032023_090302.xml X0306 4 2023-03-01 0001477449 Teladoc Health, Inc. TDOC 0001599417 Napolitano Richard J C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 false true false false CHIEF ACCOUNTING OFFICER Common Stock 2023-03-01 4 M 0 1347 A 4155 D Common Stock 2023-03-01 4 M 0 2259 A 6414 D Common Stock 2023-03-02 4 S 0 1384 25.362 D 5030 D Restricted Stock Units 2023-03-01 4 M 0 1347 0 D Common Stock 1347 2696 D Restricted Stock Units 2023-03-01 4 M 0 2259 0 D Common Stock 2259 4519 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. On March 1, 2022, the reporting person was granted 4,043 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On April 1, 2022, the reporting person was granted 6,778 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. /s/ Adam C. Vandervoort, Attorney-in-Fact 2023-03-03